Most women are familiar with PMS. Fewer are aware of PMDD – a significantly more severe premenstrual condition that can have a profound impact on mental health, relationships, and daily functioning.

Understanding the difference between PMS and PMDD symptoms is key to recognising when support may be needed.

The distinction matters.

Not just for diagnostic clarity, but because the two conditions have different mechanisms, different impacts, and different treatment pathways.

Being told your symptoms are ‘just PMS’ when they are not is one of the most common ways that people with PMDD go unsupported for years.

This article explains what PMS and PMDD are, how they differ, what drives them biologically, how hormonal testing fits into the picture, and what support is available.

Quick Facts

• PMS (Premenstrual Syndrome) affects up to 90% of people who menstruate at some point in their lives.

• PMDD (Premenstrual Dysphoric Disorder) is a distinct, formally recognised condition affecting approximately 3–8% of people who menstruate.

• PMDD is not caused by abnormal hormone levels – it results from an increased sensitivity to normal hormonal fluctuations.

• Both conditions are cyclical, occurring in the luteal phase and resolving shortly after menstruation begins.

• PMDD is classified in the DSM-5 and ICD-11 as a distinct diagnosis – not a more severe version of PMS.

• Symptoms of PMDD can include suicidal ideation during the luteal phase, which should always be treated as a medical priority.

• Tracking symptoms across at least two cycles is the most important first step toward diagnosis and appropriate support.

What Is PMS?

PMS (Premenstrual Syndrome) refers to a cluster of physical, emotional, and behavioural symptoms that occur during the luteal phase of the menstrual cycle – the days following ovulation and leading up to menstruation.

Symptoms typically ease once bleeding begins.

PMS is extremely common.

The hormonal shifts of the luteal phase – rising then falling progesterone, declining oestrogen – affect many body systems including mood, digestion, energy, and fluid balance. For most people, these changes are noticeable but manageable.

Common PMS symptoms include:

• Bloating, breast tenderness, and fluid retention

• Headaches and fatigue

• Changes in sleep or appetite

• Mild mood changes – irritability, low mood, or tension

• Reduced concentration or mild anxiety

• Food cravings

• Skin changes such as breakouts

While PMS can be uncomfortable and disruptive, most people are still able to maintain their daily routine. Where symptoms significantly impair functioning, or where emotional symptoms are intense and recurring, PMDD should be considered.

What Is PMDD?

PMDD (Premenstrual Dysphoric Disorder) is a distinct and more severe premenstrual condition, formally recognised in both the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) and the ICD-11.

It is not simply severe PMS – it has a different neurobiological basis and different diagnostic criteria.

PMDD is characterised primarily by intense emotional and psychological symptoms that occur predictably in the luteal phase and resolve shortly after menstruation begins.

The cyclical, predictable nature of symptoms – their appearance and disappearance in relation to the menstrual cycle – is central to the diagnosis.

To meet diagnostic criteria for PMDD, symptoms must:

• Occur in the luteal phase and resolve within a few days of menstruation beginning

• Follow a clear, repeatable pattern across multiple cycles

• Include at least five symptoms, with at least one being a core emotional or mood-related symptom

• Be severe enough to significantly interfere with work, relationships, or daily functioning

• Not be attributable to another condition or the exacerbation of an existing disorder

Common PMDD symptoms include:

• Persistent sadness, hopelessness, or emotional numbness

• Marked anxiety, tension, or panic attacks

• Severe irritability, anger, or mood swings that feel out of proportion

• Feeling overwhelmed, out of control, or unable to cope

• Loss of interest in usual activities, relationships, or work

• Difficulty concentrating and profound fatigue

• Sleep disturbance, appetite changes, or intense cravings

• Physical symptoms – bloating, breast pain, headaches, muscle aches

• In some cases, suicidal thoughts or significant psychological distress

If you are experiencing suicidal thoughts or severe psychological distress at any point in your cycle, please seek support immediately.

In the UK, you can contact the Samaritans or call on 116 123 (free, 24 hours) or speak to your GP as an urgent priority.

PMS vs PMDD: Key Differences at a Glance

The two conditions share timing and some symptoms, but differ significantly in severity, impact, and what drives them:

Feature	PMS	PMDD
Prevalence	Very common	Less common (≈2–8%)
Symptom severity	Mild to moderate	Severe, often debilitating
Emotional symptoms	Present but usually mild	Central and intense
Impact on daily life	Usually manageable	Often significantly impaired
Diagnosis	No formal criteria	Requires strict diagnostic criteria
Treatment approach	Lifestyle & nutritional support	Often medical + psychological support

Why Does PMDD Occur?

One of the most important things to understand about PMDD is that it is not caused by abnormal hormone levels.

People with PMDD do not have higher oestrogen or lower progesterone than those without it.

Standard hormone blood tests typically return within normal ranges.

Instead, current research points to a heightened neurological sensitivity to normal hormonal fluctuations – particularly the drop in oestrogen and progesterone that occurs in the late luteal phase.

The hormones themselves are not the problem; the brain’s response to them is.

Serotonin sensitivity

Oestrogen directly influences serotonin synthesis, receptor density, and reuptake. As oestrogen falls in the late luteal phase, serotonin activity drops – and in people with PMDD, this drop appears to have a disproportionately large effect on mood regulation, emotional reactivity, and impulse control.

This is one reason why SSRIs (selective serotonin reuptake inhibitors) can be effective in PMDD even when taken only during the luteal phase.

The GABA system

Progesterone is metabolised in the brain into a compound called allopregnanolone, which acts on GABA-A receptors – the same receptors targeted by benzodiazepines and alcohol.

In most people, allopregnanolone has a calming, anxiolytic effect. In people with PMDD, research suggests the brain may paradoxically respond to allopregnanolone with increased anxiety and emotional dysregulation rather than calm.

This abnormal GABA response is thought to be a key biological mechanism in PMDD.

Genetic susceptibility

Research has identified genetic variants – particularly in the ESC/E(Z) gene complex, which regulates how genes respond to sex hormone fluctuations – that appear in significantly higher rates in people with PMDD.

This suggests that PMDD has a partly genetic basis, explaining why it can run in families and why some people are affected while others with similar hormone profiles are not.

Overlap with other conditions

PMDD frequently co-occurs with depression, anxiety disorders, PTSD, ADHD, and borderline personality disorder.

This does not mean PMDD is caused by these conditions – but it does mean that accurate diagnosis requires careful symptom tracking to distinguish cyclical premenstrual symptoms from non-cyclical ones.

PMDD symptoms resolve after menstruation; symptoms of other mental health conditions do not.

The Role of Hormonal Testing in PMS and PMDD

Because PMDD is not caused by abnormal hormone levels, a standard hormone blood test will not diagnose it. This often leads to frustration – results come back ‘normal’ while symptoms remain severe and unexplained.

However, comprehensive hormonal testing remains highly relevant for several reasons:

Ruling out other causes

Many conditions can mimic or worsen premenstrual symptoms, including hypothyroidism, elevated prolactin, perimenopause, iron deficiency anaemia, and adrenal dysfunction.

A thorough hormonal and metabolic panel can identify or rule out these contributing factors, which is an important first step before attributing all symptoms to PMS or PMDD.

Understanding the broader hormonal picture

While PMDD itself is driven by neurological sensitivity rather than hormone level abnormalities, the overall hormonal environment still matters. Low oestrogen across the cycle, suboptimal progesterone in the luteal phase, elevated androgens, or disrupted cortisol rhythms can all amplify premenstrual symptoms.

Understanding where your hormones sit across the cycle – not just at one time point – provides a fuller picture.

Nutrient status and inflammation

Nutritional deficiencies – particularly magnesium, vitamin B6, vitamin D, and iron – are associated with worsened PMS and PMDD symptoms.

Chronic low-grade inflammation also appears to amplify luteal phase symptom severity. Testing these alongside hormones can identify modifiable contributors that are often overlooked in standard care.

Key markers worth exploring include:

Oestrogen and progesterone (ideally at multiple cycle points)
Testosterone and SHBG
TSH and free thyroid hormones
Prolactin
Cortisol
Ferritin and haemoglobin
Vitamin D, magnesium, and inflammatory markers including CRP.

How to Tell Which You Are Experiencing

Because both PMS and PMDD are defined by their relationship to the menstrual cycle rather than by a single blood test or scan, symptom tracking is the most important diagnostic tool available. It is also what any clinician will ask for.

When reviewing your symptoms, consider:

• Severity: Do symptoms interfere with work, relationships, or daily functioning – or are they uncomfortable but manageable?

• Timing: Do they reliably appear in the luteal phase (typically the 1–14 days before your period) and ease within a day or two of bleeding beginning?

• Consistency: Does the pattern repeat predictably across multiple cycles?

• Emotional intensity: Are symptoms marked by hopelessness, rage, panic, dissociation, or a feeling of being out of control – rather than just low mood or irritability?

• Symptom load: PMDD typically involves multiple symptoms occurring together, with at least one being a core emotional symptom.

• Symptom-free window: Do you have a period after menstruation begins – even a brief one – when you feel noticeably better? This follicular phase relief is a hallmark of both PMS and PMDD.

How to track your symptoms

Tracking symptoms across at least two full menstrual cycles is considered the gold standard for both PMS and PMDD assessment.

The most widely used tool is the Daily Record of Severity of Problems (DRSP), which asks you to rate mood and physical symptoms daily.

Apps such as Clue, Flo, or a simple daily diary can all serve this purpose.

When tracking, record:

• Each symptom and its severity (1–5 scale)

• Cycle day or date of last period

• Any days when symptoms significantly impaired functioning

• Days when you felt notably well or symptom-free

Bringing two cycles of tracked data to a GP appointment significantly improves the quality of the clinical conversation and reduces the risk of symptoms being dismissed or misattributed.

Management and Treatment Options

Both PMS and PMDD are manageable – but the approaches differ, and what works for one person may not work for another. Treatment should always be individualised and guided by a qualified healthcare professional.

PMS: lifestyle and nutritional support

Many people find PMS symptoms improve significantly with consistent lifestyle changes:

• Regular moderate exercise – particularly in the luteal phase, when it is most tempting to avoid it

• Blood sugar stability through regular, balanced meals and reducing refined carbohydrates and sugar

• Reducing caffeine and alcohol, both of which amplify anxiety and disrupt sleep

• Prioritising 7–9 hours of quality sleep

• Stress management practices – breathwork, yoga, time outdoors

• Targeted supplementation: magnesium glycinate (well-evidenced for PMS mood symptoms and cramps), vitamin B6, calcium, and vitamin D

PMDD: more structured intervention

PMDD typically requires more targeted treatment.

Lifestyle changes remain relevant and supportive, but are rarely sufficient on their own for moderate-to-severe PMDD. Evidence-based options include:

• SSRIs:

SSRIs (selective serotonin reuptake inhibitors) are currently the first-line medical treatment for PMDD. They can be taken continuously or only during the luteal phase, with many people finding luteal-phase dosing highly effective. They work differently in PMDD than in depression – the effect is rapid, reflecting a direct impact on neurosteroid sensitivity rather than traditional antidepressant mechanisms.

• Hormonal treatments:

Continuous combined contraceptives (particularly those containing drospirenone) can be effective by suppressing the hormonal fluctuations that trigger PMDD symptoms. GnRH analogues – which temporarily suppress ovarian function – are used in severe, treatment-resistant cases.

• CBT and psychological support:

Cognitive behavioural therapy adapted for PMDD has good evidence, helping to develop strategies for managing the predictable cyclical nature of symptoms.

• Nutritional and lifestyle foundations:

Reducing alcohol, stabilising blood sugar, improving sleep, and addressing nutrient deficiencies all support the nervous system in ways that can reduce symptom severity, even if they do not resolve PMDD alone.

• Specialist care:

For severe or treatment-resistant PMDD, referral to a specialist service – such as the National Association for Premenstrual Syndromes (NAPS) or a menstrual health clinic – may be appropriate.

Why the Distinction Matters

Conflating PMS and PMDD – or dismissing PMDD as ‘bad PMS’ – has real consequences.

People with PMDD who are told their symptoms are normal, or are offered only lifestyle advice that does not adequately address the neurobiological component, can spend years in unnecessary suffering without appropriate support.

Understanding which condition you are experiencing matters because:

• It validates that what you are experiencing is real, recognised, and diagnosable – not imagined or exaggerated

• It directs you toward the right treatment pathway – lifestyle support for PMS, medical and psychological support for PMDD

• It enables earlier intervention, which is associated with better long-term outcomes

• It reduces the risk of PMDD symptoms being misdiagnosed as bipolar disorder, borderline personality disorder, or general depression – all of which are common misdiagnoses

• It empowers informed conversations with healthcare providers

You Are Not Imagining It

If premenstrual symptoms are affecting your quality of life – your relationships, your work, your sense of self – they deserve to be taken seriously.

Not minimised, not normalised, and not managed in isolation without proper support.

Tracking your cycle is the most powerful first step.

Understanding the hormonal and nutritional picture beneath the symptoms is the second.

Finding the right clinical support – one that takes both the psychological and physiological dimensions seriously – is the third.

Both PMS and PMDD are manageable.

With the right information and the right support, quality of life can improve significantly.

Frequently Asked Questions

Is PMDD a mental illness?

PMDD is formally classified in the DSM-5 as a depressive disorder and in the ICD-11 as a condition affecting mental health – but this classification reflects its primary emotional and psychological symptoms, not that it is ‘all in the mind’. PMDD has a clear neurobiological basis involving the brain’s sensitivity to hormonal fluctuations.

It is better understood as a neuroendocrine condition that affects mood and behaviour, driven by brain chemistry responses to the menstrual cycle.

How is PMDD diagnosed?

PMDD is diagnosed through prospective symptom tracking across at least two menstrual cycles using a validated tool such as the DRSP (Daily Record of Severity of Problems).

There is no blood test that diagnoses PMDD.

A diagnosis requires at least five symptoms to be present in the luteal phase, with at least one being a core emotional symptom, and symptoms must be severe enough to impair daily functioning and resolve after menstruation begins.

Can PMDD go away on its own?

PMDD does not typically resolve without intervention, though its severity can fluctuate across life stages – some people notice changes during pregnancy, after childbirth, or approaching perimenopause.

For most people, PMDD requires active management. The good news is that it is highly treatable, with multiple evidence-based options available. Without treatment, PMDD tends to persist and can worsen over time.

Can lifestyle changes alone treat PMDD?

For mild PMDD, lifestyle changes – particularly improving sleep, reducing alcohol and caffeine, stabilising blood sugar, regular exercise, and addressing nutritional deficiencies – can make a meaningful difference to symptom severity.

For moderate-to-severe PMDD, lifestyle changes are an important foundation but are rarely sufficient on their own. Most people with significant PMDD benefit from combining lifestyle support with medical or psychological intervention.

What is the difference between PMS and perimenopause?

PMS is cyclical – symptoms occur in the luteal phase and resolve with menstruation.

Perimenopausal symptoms can occur at any point in the cycle and are often associated with increasing cycle irregularity, changes in flow, and symptoms that persist across the whole month.

In perimenopause, declining and fluctuating oestrogen can also worsen pre-existing PMS or PMDD.

Blood testing – particularly FSH and oestradiol – alongside symptom tracking can help distinguish between the two.

Do blood tests help with PMS or PMDD?

Blood tests do not diagnose PMS or PMDD – but they are valuable for ruling out other causes of premenstrual symptoms (such as thyroid dysfunction, iron deficiency, or hormonal imbalance), identifying nutritional deficiencies that may be amplifying symptoms (magnesium, vitamin D, B vitamins), and understanding the broader hormonal environment. A comprehensive panel gives a fuller picture of what is driving symptoms and what can be addressed directly.

Can PMDD be confused with bipolar disorder?

Yes – PMDD is frequently misdiagnosed as bipolar disorder, borderline personality disorder, or recurrent depressive disorder.

The key distinguishing feature is cyclicality: PMDD symptoms follow a predictable monthly pattern tied to the menstrual cycle and resolve after menstruation begins.

Bipolar disorder and other conditions are not cycle-dependent in this way. Careful prospective symptom tracking is essential to making this distinction accurately.

References

This article was written by Holly Devine and reviewed for clinical accuracy. It is intended for informational purposes only and does not constitute medical advice.

If you are experiencing severe premenstrual symptoms, please consult a qualified healthcare professional.

If you are in crisis, contact the Samaritans on 116 123 (free, 24 hours).

Diagnosis and classification

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). APA Publishing. 2013.

• World Health Organization. International Classification of Diseases, Eleventh Revision (ICD-11). who.int (2019).

• Epperson CN, Steiner M, Hartlage SA, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. American Journal of Psychiatry. 2012;169(5):465–475.

Biological mechanisms

• Rubinow DR, Schmidt PJ. Sex differences and the neurobiology of affective disorders. Neuropsychopharmacology. 2019;44(1):111–128.

• Backstrom T, Andreen L, Birzniece V, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs. 2003;17(5):325–342.

• Dubey N, Hoffman JF, Schuebel K, et al. The ESC/E(Z) complex, an intrinsic cellular molecular pharmacologic target of progesterone receptor membrane component 1. Molecular Psychiatry. 2017;22(8):1147–1158.

Treatment

• Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews. 2013;6:CD001396.

• Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200–1210.

• Nevatte T, O’Brien PM, Bäckström T, et al. ISPMD consensus on the management of premenstrual disorders. Archives of Women’s Mental Health. 2013;16(4):279–291.

Nutritional factors

• Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Canadian Journal of Clinical Pharmacology. 2009;16(3):e407–e429.

• Wyatt KM, Dimmock PW, Jones PW, O’Brien PM. Efficacy of vitamin B6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318(7195):1375–1381.

PMS vs PMDD: Symptoms, Differences and What to Do Next